louisakewell, Author at European Medical Journal - Page 27 of 153

Continue
8 Mins
7th June 2018

New Insights into the Role of Phosphoinositide 3-Kinase Activity in the Physiology of Immature Oocytes: Lessons from Recent Mouse Model Studies

The immature oocytes within primordial follicles are arrested at Prophase I of meiosis and remain dormant until awakened by an increase in intracellular…
7 Mins
7th June 2018

The Adverse Impact of Sarcopenia and Visceral Fat Deposition on the Course of Hepatocellular Carcinoma and the Role of Nutritional Interventions

There is mounting evidence to support the impact of sarcopenia on the prognosis of a wide range of clinical conditions. This review examines the…
17 Mins
31st May 2018

Review of the 53rd International Liver Congress™ 2018

Bigger and better than ever before, this year’s dynamic EASL ILC was held in Paris, France from the 11th–15th April 2018. This historic city, long…
1 Mins
31st May 2018

Resolution of Ascites, Hepatic Encephalopathy, and Variceal Bleeding in Patients with Hepatitis C Virus and Decompensated Cirrhosis Who Received All-Oral Direct-Acting Antiviral Treatment

Worldwide, 185 million people are infected with the hepatitis C virus (HCV);1 approximately 12% of these individuals have manifestations of decompensated…
9 Mins
31st May 2018

Editor's Pick: Primary Hepatic Angiosarcoma: A Brief Review of the Literature

Primary hepatic angiosarcoma (HAS) is a liver tumour of endothelial cell origin. It is the most common malignant mesenchymal tumour of the liver…
1 Mins
31st May 2018

A Comparison of Renal Function Before and After Treatment of Chronic Hepatitis C Infection in Patients Who Achieve Sustained Virological Response with Direct-Acting Antivirals

Approximately 3 million people have chronic hepatitis C virus (HCV) infection in the USA. However, there are limited data with regard to the effect of…
2 Mins
31st May 2018

OPTIMIS: Real-World Data in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolisation: Second Interim Analysis

Transarterial chemoembolisation (TACE) is the most common treatment modality for hepatocellular carcinoma (HCC) worldwide, often used to treat cases…
8 Mins
31st May 2018

Acute Fatty Liver of Pregnancy: Better Understanding of Pathogenesis and Earlier Clinical Recognition Results in Improved Maternal Outcomes

Acute fatty liver of pregnancy (AFLP) is an uncommon disorder affecting women in late pregnancy. It is increasingly recognised as an important cause of…
2 Mins
31st May 2018

Acute Liver Failure: Time to Review Our Follow-Up Policy?

Acute liver failure (ALF) is a rare but serious clinical condition resulting from sudden, massive loss of hepatic parenchyma and metabolic functions.
9 Mins
31st May 2018

Targeting the Relaxin Pathway for Liver Disease Treatment

Hepatic fibrosis is a progressive disease with few treatment options outside of transplantation. Relaxin is a member of the insulin/relaxin superfamily…